Intelligent Bio Solutions Completes In-Clinic Portion of Pharmacokinetic (PK) Study Part of 510(k) Pathway for Approval & Commences Review of Results
June 28, 2024 08:30 ET
|
Intelligent Bio Solutions, Inc.
NEW YORK, June 28, 2024 (GLOBE NEWSWIRE) -- Intelligent Bio Solutions Inc. (Nasdaq: INBS) ("INBS" or the "Company"), a medical technology company delivering intelligent, rapid, non-invasive testing...
Intelligent Bio Solutions Expands Presence in the UK Retail Sector with Major Account Acquisitions
June 27, 2024 08:30 ET
|
Intelligent Bio Solutions, Inc.
NEW YORK, June 27, 2024 (GLOBE NEWSWIRE) -- Intelligent Bio Solutions Inc. (Nasdaq: INBS) ("INBS" or the "Company"), a medical technology company delivering intelligent, rapid, non-invasive testing...
Psychemedics Unveils Inaugural Insights Report: Revealing Drug Trends Through Hair Testing
June 21, 2024 10:00 ET
|
Psychemedics Corporation
Psychemedics Corporation releases its inaugural 2024 Insights Report, offering a comprehensive analysis of workplace drug trends from 2023.
Intelligent Bio Solutions Begins Subject Dosing and Sampling for FDA 510(k) Pharmacokinetic (PK) Study for its Intelligent Fingerprinting Drug Screening Technology
June 18, 2024 08:30 ET
|
Intelligent Bio Solutions, Inc.
NEW YORK, June 18, 2024 (GLOBE NEWSWIRE) -- Intelligent Bio Solutions Inc. (Nasdaq: INBS) ("INBS" or the "Company"), a medical technology company delivering intelligent, rapid, non-invasive testing...
Global $19.5 Bn Drug Screening Market Analysis/Forecasts to 2029
June 04, 2024 11:51 ET
|
Research and Markets
Dublin, June 04, 2024 (GLOBE NEWSWIRE) -- The "Global Drug Screening Market by Product (Rapid Testing (Urine, Oral), Analytical (Breathalyzer, Immunoassay, Chromatography)), Sample (Urine, Breath,...
First Advantage Releases 2024 Global Trends Report
April 23, 2024 06:15 ET
|
First Advantage
For the Second Year in a Row, First Advantage Global Trends Report Finds Managing Risk is the Most Important Factor for Background Screening Programs
Psychemedics Recognized as a Top 10 Employee Health Testing Services Provider
March 21, 2024 09:00 ET
|
Psychemedics Corporation
Psychemedics Corporation announces its recognition as one of the Top 10 Employee Health Testing Services Providers for 2024 by ManageHR
Global Drug Screening Research Report 2023: Market to Reach $7.7 Billion by 2030 - Automation and High-Throughput Systems Transforming the Drug Screening Landscape
January 24, 2024 06:07 ET
|
Research and Markets
Dublin, Jan. 24, 2024 (GLOBE NEWSWIRE) -- The "Global Drug Screening Market 2030 by Product, Sample, End-user Industry & Region - Partner & Customer Ecosystem Competitive Index &...
SHRM President and CEO Johnny C. Taylor, Jr. Returns as Keynote Speaker for First Advantage’s Annual Collaborate Conference
January 09, 2024 07:00 ET
|
First Advantage
SHRM President and CEO Johnny C. Taylor, Jr. Returns as Keynote Speaker for First Advantage’s Annual Collaborate Conference
The Drug Abuse Testing Industry 2024-2030: Urine-based Tests Dominate the Landscape, with China Emerging as a Key Player
November 06, 2023 06:38 ET
|
Research and Markets
Dublin, Nov. 06, 2023 (GLOBE NEWSWIRE) -- The "Drug Abuse Testing Market, Size, Global Forecast 2024-2030, Industry Trends, Growth, Share, Outlook, Impact of Inflation, Opportunity Company Analysis"...